Exited SVLSF investments

Please see below a list of our exited investments

To go to individual portfolio companies websites please click on company logo.




Allos Therapeutics: US

First investment: 1998 - Early Stage

Developing and commercializing innovative small molecule therapeutics for the treatment of cancer.

---

Axys Pharmaceuticals: US

First investment: 1994 - Early Stage

Protease-inhibitor based products for cancer & inflammatory diseases.

---

Cerebrus: UK

First investment: 1995 - Start Up

CNS drug discovery (Acquired by Nigra, which was then bought by Vernalis)

---

Coral Therapeutics: US

First investment: 1994 - Start Up

Provision of blood handling services to hospitals.

---

Cytomed: US

First investment: 1997 - Early Stage

Leukotriene inhibitors for asthma (Acquired by LeukoSite Inc and then by Millenium).

---

Euro Dentalversand: Germany

First investment: 2000 - Buy Out

Mail order dental consumables.

---

Geltex Pharmaceuticals: US

First investment: 1994 - Early Stage
Further investment: 1998 - Expansion

Development of novel non-absorbed pharmaceuticals.

Acquired by Genzyme Corporation after our exit.

---

General Surgical Innovations: US

First investment: 1995 - Early Stage

Minimally invasive approach to hernia repair and incontinence (purchased by United States Surgical).

---

Heritage Health Systems: US

First investment: 1995 - Early Stage

Physician practice management.

---

Incyte Pharmaceuticals: UK

First investment: 1996 - Start Up

Functional genomics (Acquired by Incyte).Formerly known as Incyte Pharmaceuticals

---

JC Nationwide: US

First investment: 1995 - Buy Out

Physician recruitment agency.

---

Kinetix Pharmaceuticals: US

First investment: 1999 - Start Up

Kinase targeted drug discovery (Acquired by Amgen).

---

Leica Microsystems: Germany

First investment: 1998 - Buy Out

Manufactures and markets microscopes and neurosurgical equipment.

---

LeukoSite: US

First investment: 1994 - Start Up

Treatment of Inflammatory diseases and cancer (Acquired by Millenium).

---

Micromass: UK

First investment: 1996 - Buy Out

Minimally invasive approach to hernia repair and incontinence (purchased by Waters).

---

Nexan: UK

First investment: 1996 - Start Up

Remote telemonitoring devices.

---

OMS Foundations: US

First investment: 1998 - Early Stage

Oral maxillofacial physician practice management.

---

Orthovita: US

First investment: 1997 - Early Stage

Novel bone substitute materials.

---

Pelton & Crane: US

First investment: 1997 - Buy Out

Sterilization equipment.

---

Shire Pharmaceuticals: US

First investment: 1994 - Early Stage

Osteoporosis and Alzheimer's disease.

---

Sirona Dental Systems: Germany

First investment: 1997 - Buy Out

Dental equipment manufacturer.

---

Strides Arcolab: India

First investment: 1997 - Expansion

Manufacturer of generic pharmaceuticals.

---

TLC Vision: US

First investment: 1995 - Expansion

Service provider for laser-based ophthalmic surgery Formerly known as Laservision.

---

Triangle Pharmaceuticals: US

First investment: 1995 - Start Up

Antiviral and anticancer drug development (Acquired by Gilead).

---

Vanguard Medica (Vernalis): UK

First investment: 1995 - Early Stage

Antiviral and anticancer drug development. (Acquired by Vernalis)

---

Vintage BioMed: US

First investment: 1996 - Seed

Capital equipment leasing and maintenance.







Aderis Pharmaceuticals: US

First investment: 2001 - Expansion

Cardiovascular, renal and neurological disease focused therapeutics focused upon making a significant difference to people living with cardiovascular, renal and neurological diseases.

---

Argonaut Technologies: US

First investment: 1999 - Expansion

Chemistry instrumentation for accelerated synthesis of novel organic molecules. Bought by Biotage after our exit.

---

Auxilium Pharmaceuticals: US

First investment: 2001 - Early Stage

Male Hormone Replacement Therapy.

---

Cardiac Support Systems: US

First investment: 2000 - Seed

This was an innovation factory company.

---

Easychem: US

First investment: 2000 - Seed

B2B chemical e-commerce electronic marketplace.

---

eMed Technologies: US

First investment: 2000 - Expansion

Delivery of medical images over the internet.

---

Expand Sante: France

First investment: 2000 - Seed

French pharmaceutical contract sales organisation.

---

Eyetech Pharmaceuticals: US

First investment: 2000 - Early Stage

Bought by OSI Pharmaceuticals after our exit. Opthalmolological drug development.

---

KuDOS Pharmaceuticals: UK

First investment: 1999 - Start Up

Oncology drug development.

---

Orchid Chemicals and Pharmaceuticals: India

Private investment in Public Equity
First investment: 1999 - Expansion

Manufacture of bulk generic pharmaceuticals.

---

Physicians Dialysis: US

First investment: 2001 - Buy Out

Consolidator of renal dialysis centers (Purchased by DaVita).

---

Quantum Dot: US

First investment: 2000 - Early Stage

Nanocrystal biological reagents.

---

Third Wave Technologies: US

First investment: 1999 - Expansion

Products for analysing genetic variations

---

Versicor: US

First investment: 1999 - Expansion

Drug development for infectious diseases (Changed name to Vicurion Pharmaceuticals in 2003)




Eunoe: US

First investment: 2003 - Expansion

Treatment of neurological disorders through cerebrospinal fluid management (CSF).

---

GlycoFi: US

First investment: 2002 - Start Up

Production and engineering of therapeutics proteins.

---

PowderMed: UK

First investment: 2004 - Early Stage

Development of therapeutic DNA vaccines in the areas of chronic viral diseases and cancer.

---

Rinat Neuroscience: US

First investment: 2003 - Early Stage

Developing proteins for the treatment of diseases and disorders of the nervous system.